Rituxan (rituximab) - Hepatitis B Virus (hbv) Recurrence In Patients: Updates On Screening And Management - For The Public

RITUXAN Recall Summary Rituxan (rituximab), a drug used to treat certain cancers and autoimmune diseases, can cause hepatitis B virus to reactivate in patients who previously had or carry the virus but show no symptoms. Health Canada is updating screening and management recommendations to help identify and monitor patients at risk for this serious complication. The recall affects all Rituxan patients across Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2013-07-29

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/f4258711-4aeb-4908-ad7f-4ef12cf416d3